Actively Recruiting
Positron Emission Mammography and Liquid Biopsy in Women With High-risk Breast Screenings
Led by University Health Network, Toronto · Updated on 2026-04-29
100
Participants Needed
1
Research Sites
201 weeks
Total Duration
On this page
Sponsors
U
University Health Network, Toronto
Lead Sponsor
R
Radialis Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this research study is to evaluate the performance of two experimental tests, namely Liquid Biopsy and Positron Emission Mammography (PEM) in women at high risk of breast cancer. The plan for this study is to assess whether findings from the combination or each individual test can assist radiologists in visualizing and characterizing beast abnormalities. Liquid Biopsy is a blood test that can detect early tumours in patients with malignancies, while PEM is an imaging tool equipped with a high-resolution camera that uses a low dose of injected positron emitting isotope to locate breast tumours. Participation in this study entails a blood draw for Liquid Biopsy test and a PEM imaging exam before undergoing a magnetic resonance imaging (MRI) - guided biopsy for a suspicious breast lesion. If PEM and/or Liquid Biopsy provide accurate information to assist radiologists in visualizing and characterizing breast abnormalities, this method may serve as the first step towards establishing these genomic and new imaging technologies as new diagnostic modalities and ultimately reduce the unnecessary biopsies and anxiety in high-risk populations.
CONDITIONS
Official Title
Positron Emission Mammography and Liquid Biopsy in Women With High-risk Breast Screenings
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals who are older than 18 years of age
- Individuals who are planned to undergo an MRI-guided biopsy based on high-risk screening imaging detected lesions
- Individuals with the ability to understand and the willingness to sign a written informed consent document
You will not qualify if you...
- High-risk individuals with screening-imaging studies without suspicious lesions detected by the standard of care mammogram and/or MRI
- Individuals who are pregnant or who think they may be pregnant
- Individuals who are breast-feeding
- Individuals with known allergies to F-18 FDG
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Health Network
Toronto, Ontario, Canada, M5G 2M9
Actively Recruiting
Research Team
S
Samira Taeb, MSc
CONTACT
V
Vivianne Freitas, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here